LATe Cerclage in High-risk Pregnancies (LATCH) - Trial NCT06036446
Access comprehensive clinical trial information for NCT06036446 through Pure Global AI's free database. This phase not specified trial is sponsored by Thomas Jefferson University and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 329 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Thomas Jefferson University
Timeline & Enrollment
N/A
Nov 10, 2023
Feb 01, 2027
Primary Outcome
Incidence of preterm birth 37 weeks
Summary
The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of
 preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL)
 ≤25mm between 24 0/7-26 6/7 weeks.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06036446
Non-Device Trial